close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Gabriela Hobbs

location-icon

Boston, MA

LOCATION OF PRACTICE
Massachusetts General Hospital
MEDICAL Specialty:

Bone Marrow Biopsy, Myeloproliferative Disorders, Thrombocytosis



55 FRUIT ST # STREET1, BOSTON, MA, 021142621
55 FRUIT ST # STREET1, BOSTON, MA, 021142621
617-724-1124
NPI Number
1285893453
ABOUT

Gabriela Hobbs, MD, is an internist in Boston, MA. She frequently treats conditions like Myeloproliferative Disorders and Thrombocytosis. Hobbs completed a fellowship at Memorial Hospital For Cancer and Allied Diseases.

Education & Certifications
Fellowship

Memorial Hospital For Cancer and Allied Diseases

Internship

Brigham and Womens Hospital

Board Certifications

Hematology, Internal Medicine and Medical Oncology

Dr. Gabriela Hobbs’s Office Locations
1

Massachusetts General Hospital

Massachusetts General Hospital, 55 Fruit St, Boston, MA02114

Directions
2

Office

Office, 52 Second Ave Ste 1110, Waltham, MA02451

Directions
3

Office

Office, 55 Fruit St Ste 9, Boston, MA02114

Directions
Dr. Gabriela Hobbs profile image

Published Articles

Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.- 2026 Sep 3
Defining and predicting disease progression in myeloproliferative neoplasms: a proposed biomarker-driven approach.- 2026 Sep 1
Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.- 2026 Aug 27
Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.- 2026 Aug 20
Risk factors associated with high probability of pulmonary hypertension in patients with myeloproliferative neoplasms.- 2026 Jul 21
Overcoming Daraxonrasib Resistance: Allele-Specific Mechanisms Guide Salvage Therapy in Pancreatic Cancer.- 2026 Jul 10
Clinical outcomes of combination treatment with FMS-like tyrosine kinase 3 (FLT3) and isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors in patients with acute myeloid leukaemia.- 2026 Jul 12
Clinical features and outcomes of MPN with concurrent MPL and JAK2/CALR Mutations.- 2026 Aug
Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.- 2026 Jun 3
Between the classic hit and the modern sequel: transition dosing between peginterferon alfa-2a and ropeginterferon alfa-2b for myeloproliferative neoplasms.- 2026 Jun 24

Clinical Trials

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients
A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Ruxolitinib + Allogeneic Stem Cell Transplantation in AML
Ruxolitinib in Thrombocythemia and Polycythemia Vera
Study of Regorafenib in Patients With Advanced Myeloid Malignancies
PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Momelotinib During and After HCT in Myelofibrosis

Other Specialists treating Bone Marrow Biopsy, Myeloproliferative Disorders, Thrombocytosis in Boston, MA

See All Doctors

Dr. Mei Tang

Specialty: Macroglobulinemia (incl. Waldenstrom's ), Myeloproliferative Disorders, Head and Neck Cancer

My Resources
location-icon

The Johns Hopkins Hospital

My Resources

Dr. Maureen Achebe

Specialty: Anemia, Myeloproliferative Disorders, Retroperitoneum Cancer

My Resources
location-icon

Brigham and Women's Hospital

My Resources

Dr. Martha Wadleigh

Specialty: Chronic Myeloid Leukemia (CML), Myeloproliferative Disorders, Acute Leukemia

My Resources
location-icon

Brigham and Women's Hospital

My Resources

Dr. Barbara Degar

Specialty: Acute Lymphoid Leukemia, Acute Leukemia, Bone Marrow Biopsy

My Resources
location-icon

Beverly Hospital

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider